| Income Statement | 2025-06-30 | 2025-03-31 | ||
|---|---|---|---|---|
| Net revenues | 7,790,865 | 10,863,443 | ||
| Cost of revenues | 7,285,113 | 10,170,802 | ||
| Gross profit (loss) | 505,752 | 692,641 | ||
| Sales and marketing | 343,383 | 65,217 | ||
| General and administrative | 4,859,949 | 31,172,920 | ||
| Depreciation and amortization | 802,796 | 802,872 | ||
| Total operating expenses | 6,006,128 | 32,041,009 | ||
| Loss from operations | -5,500,376 | -31,348,368 | ||
| Other income | 11,952 | 11,955 | ||
| Interest expense, net | 1,184,040 | 1,094,490 | ||
| Total other expense, net | -1,172,088 | -1,082,535 | ||
| Net loss before income taxes | -6,672,464 | -32,430,903 | ||
| Provision for income taxes | 0 | - | ||
| Net loss | -6,672,464 | -32,430,903 | ||
| Net loss per common share - basic | -0.11 | -0.62 | ||
| Net loss per common share - diluted | -0.11 | -0.62 | ||
| Weighted average common shares outstanding - basic | 61,771,127 | 51,916,787 | ||
| Weighted average common shares outstanding - diluted | 61,771,127 | 51,916,787 | ||
Wellgistics Health, Inc. (WGRX)
Wellgistics Health, Inc. (WGRX)